非セミノーマ精巣腫瘍(Nonseminomatous Testicular Cancer):世界の治験レビュー(2015年上半期版)

◆英語タイトル:Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2601CTIDB
◆発行会社(調査会社):GlobalData
◆発行日:2015年3月27日
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における非セミノーマ精巣腫瘍(Nonseminomatous Testicular Cancer) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 非セミノーマ精巣腫瘍(Nonseminomatous Testicular Cancer)
  - 当レポートの概要
・非セミノーマ精巣腫瘍(Nonseminomatous Testicular Cancer):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015″ provides data on the Nonseminomatous Testicular Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nonseminomatous Testicular Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nonseminomatous Testicular Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Nonseminomatous Testicular Cancer 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Nonseminomatous Testicular Cancer 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Drugs 24
Clinical Trial Overview of Top Institutes / Government 25
Memorial Sloan Kettering Cancer Center 25
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 25
National Cancer Institute 26
Clinical Trial Overview of National Cancer Institute 26
Abramson Cancer Center 27
Clinical Trial Overview of Abramson Cancer Center 27
Cambridge University Hospitals NHS Foundation Trust 28
Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 28
City of Hope 29
Clinical Trial Overview of City of Hope 29
Deutsche Krebshilfe e.V. 30
Clinical Trial Overview of Deutsche Krebshilfe e.V. 30
European Organization for Research and Treatment of Cancer 31
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 31
Indiana University School of Medicine 32
Clinical Trial Overview of Indiana University School of Medicine 32
Institute of Cancer Research 33
Clinical Trial Overview of Institute of Cancer Research 33
Masonic Cancer Center 34
Clinical Trial Overview of Masonic Cancer Center 34
Five Key Clinical Profiles 35
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Disclaimer 65
Source 66

List of Tables
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 6
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 13
Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 16
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 17
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Nonseminomatous Testicular Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 21
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Nonseminomatous Testicular Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 24
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 25
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 26
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2015* 27
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2015* 28
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope, 2015* 29
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Deutsche Krebshilfe e.V., 2015* 30
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 31
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2015* 32
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Cancer Research, 2015* 33
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2015* 34

List of Figures
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 13
Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 16
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Nonseminomatous Testicular Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 24
GlobalData Methodology 64

【レポートのキーワード】

非セミノーマ精巣腫瘍(Nonseminomatous Testicular Cancer)、治験、臨床試験、治験、治療薬

★調査レポート[非セミノーマ精巣腫瘍(Nonseminomatous Testicular Cancer):世界の治験レビュー(2015年上半期版)] (コード:GDHC2601CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[非セミノーマ精巣腫瘍(Nonseminomatous Testicular Cancer):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆